Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study.
New analysis shows Novartis drug Gilenya® significantly reduced rate of brain volume loss across three large Phase III studies
Pharmacodynamics of Dimethyl Fumarate are Tissue-specific and Involve NRF2-dependent and -independent Mechanisms.
Differential Reconstitution of T Cell Subsets following Immunodepleting Treatment with Alemtuzumab (Anti-CD52 Monoclonal Antibody) in Patients with Relapsing-Remitting Multiple Sclerosis.
A benefit-risk analysis of natalizumab in the treatment of patients with multiple sclerosis when considering the risk of progressive multifocal leukoencephalopathy.
GEMS Project: A Platform to Investigate Multiple Sclerosis Risk.
A Pilot Trial of Interferon beta-1a in Alzheimer's Disease
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.
Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation.
Studying both sexes: a guiding principle for biomedicine.
Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM)
Pervasive Axonal Transport Deficits in Multiple Sclerosis Models.
Focal vibration in neurorehabilitation.
Foxp3(+) Treg cells in the inflamed CNS are insensitive to IL-6-driven IL-17 production.
EMD Serono Takes on Exclusive Promotion of Rebif® (interferon beta-1a) in the US
Glatiramer Acetate and Nanny Proteins Restrict Access of the Multiple Sclerosis Autoantigen Myelin Basic Protein to the 26S Proteasome.
Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months.
Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years.
Astrocyte-derived lactosylceramide implicated in multiple sclerosis.
Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines.
Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.
Patterns of Treatment Switching in Multiple Sclerosis Therapies in US Patients Active on Social Media: Application of Social Media Content Analysis to Health Outcomes Research.
A much-needed focus on progression in multiple sclerosis.
Severe liver dysfunction possibly caused by the combination of interferon beta-1b therapy and melilot (sweet clover) supplement.

Pages